Xiaojian Zhu

1.4k total citations
68 papers, 959 citations indexed

About

Xiaojian Zhu is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Xiaojian Zhu has authored 68 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Oncology, 22 papers in Molecular Biology and 20 papers in Immunology. Recurrent topics in Xiaojian Zhu's work include CAR-T cell therapy research (37 papers), Immune Cell Function and Interaction (13 papers) and Virus-based gene therapy research (12 papers). Xiaojian Zhu is often cited by papers focused on CAR-T cell therapy research (37 papers), Immune Cell Function and Interaction (13 papers) and Virus-based gene therapy research (12 papers). Xiaojian Zhu collaborates with scholars based in China, United States and United Kingdom. Xiaojian Zhu's co-authors include Zhichao Chen, Ping Zou, Qiubai Li, Jianfeng Zhou, Zhaodong Zhong, Fankai Meng, Hongxiang Wang, Fanjun Cheng, An‐Yuan Guo and Jue Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Cancer Research.

In The Last Decade

Xiaojian Zhu

58 papers receiving 953 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaojian Zhu China 18 535 426 220 163 162 68 959
Catalin Mihalcioiu Canada 14 391 0.7× 422 1.0× 283 1.3× 155 1.0× 45 0.3× 38 1000
Francis Mussai United Kingdom 18 438 0.8× 510 1.2× 284 1.3× 591 3.6× 296 1.8× 40 1.4k
Denise Toscani Italy 18 571 1.1× 557 1.3× 147 0.7× 199 1.2× 570 3.5× 48 1.2k
Frédéric Barabé Canada 20 732 1.4× 286 0.7× 132 0.6× 348 2.1× 416 2.6× 38 1.3k
Hyung‐Gyoon Kim United States 17 541 1.0× 405 1.0× 189 0.9× 197 1.2× 121 0.7× 33 1.0k
Dina Stroopinsky United States 14 392 0.7× 295 0.7× 144 0.7× 315 1.9× 193 1.2× 46 835
Tae Kon Kim United States 15 311 0.6× 417 1.0× 119 0.5× 470 2.9× 177 1.1× 46 1.0k
Andrea Pelosi Italy 18 489 0.9× 202 0.5× 300 1.4× 297 1.8× 81 0.5× 35 912
Laurence Maggiorella France 11 340 0.6× 291 0.7× 153 0.7× 73 0.4× 105 0.6× 17 793
Bonnie K. Arendt United States 16 563 1.1× 407 1.0× 130 0.6× 558 3.4× 462 2.9× 23 1.3k

Countries citing papers authored by Xiaojian Zhu

Since Specialization
Citations

This map shows the geographic impact of Xiaojian Zhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojian Zhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojian Zhu more than expected).

Fields of papers citing papers by Xiaojian Zhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojian Zhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojian Zhu. The network helps show where Xiaojian Zhu may publish in the future.

Co-authorship network of co-authors of Xiaojian Zhu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojian Zhu. A scholar is included among the top collaborators of Xiaojian Zhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojian Zhu. Xiaojian Zhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jue, Na Wang, Jinhuan Xu, et al.. (2025). Long-term Therapy Outcomes of CD19/22 CAR T Cell Alone or with Autologous Stem Cell Transplantation for Relapsed/Refractory DLBCL. Blood Cancer Discovery. 7(1). 142–153.
2.
Zhao, Xiaying, et al.. (2025). Mesenchymal Stromal Cells: Bridging the Gaps in Hematologic Disease Therapy. Stem Cell Reviews and Reports. 22(1). 434–488.
3.
Zhu, Xiaojian, et al.. (2025). CD70-targeted CAR-T/NK therapy: Rationale, advances, and future directions. Translational Oncology. 62. 102555–102555.
4.
5.
Wu, Jiaying, et al.. (2024). Updates of primary central nervous system lymphoma. Therapeutic Advances in Hematology. 15. 1574176770–1574176770. 2 indexed citations
6.
Zhu, Xiaojian, et al.. (2024). The Changes in the Quantity of Lymphocyte Subpopulations during the Process of Sepsis. International Journal of Molecular Sciences. 25(3). 1902–1902. 7 indexed citations
7.
8.
9.
Zhu, Xiaojian, et al.. (2024). Advances in second hematopoietic stem cell transplantation. Frontiers in Immunology. 15. 1428101–1428101.
10.
Zhu, Xiaojian, et al.. (2024). CAR-T cell combination therapies in hematologic malignancies. Experimental Hematology and Oncology. 13(1). 69–69. 12 indexed citations
11.
Zhu, Xiaoying, Zhaodong Zhong, Fankai Meng, et al.. (2023). CD26 CAR-T cells have attenuated mitochondrial and glycolytic metabolic profiling. Immunopharmacology and Immunotoxicology. 45(6). 709–718. 1 indexed citations
12.
Cheng, Jiali, Tong Ge, Xiaojian Zhu, et al.. (2023). Preclinical development and evaluation of nanobody-based CD70-specific CAR T cells for the treatment of acute myeloid leukemia. Cancer Immunology Immunotherapy. 72(7). 2331–2346. 22 indexed citations
13.
Mu, Wei, Meilan Zhang, Guang Hu, et al.. (2023). Case report: Differential diagnosis of highly amplified anti-CD5 CAR T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma. Frontiers in Immunology. 14. 1280007–1280007. 2 indexed citations
14.
Sun, Yuqian, et al.. (2021). A Case of Severe COVID-19 in a Patient with Acute Graft-versus-Host Disease after Haploidentical Transplantation. SHILAP Revista de lepidopterología. 2021. 1–5. 1 indexed citations
15.
Zhou, Shu, Weiming Li, Yi Xiao, et al.. (2020). A novel chimeric antigen receptor redirecting T-cell specificity towards CD26+ cancer cells. Leukemia. 35(1). 119–129. 21 indexed citations
16.
Jiang, Lin, Hongxiang Wang, Xiaoying Zhu, et al.. (2019). The Impact of Tyrosine Kinase Inhibitors on Chronic Myeloid Leukemia Stem Cells and the Implication in Discontinuation. Stem Cells and Development. 28(22). 1480–1485. 3 indexed citations
17.
Zhou, Shu, Xiaoying Zhu, Xiaoying Zhu, et al.. (2019). T cells expressing CD26-specific chimeric antigen receptors exhibit extensive self-antigen-driven fratricide. Immunopharmacology and Immunotoxicology. 41(4). 490–496. 9 indexed citations
18.
Wei, Jia, Xiaojian Zhu, Xia Mao, et al.. (2019). Severe early hepatitis B reactivation in a patient receiving anti-CD19 and anti-CD22 CAR T cells for the treatment of diffuse large B-cell lymphoma. Journal for ImmunoTherapy of Cancer. 7(1). 315–315. 47 indexed citations
19.
Zhang, Hongmei, Qing Li, Xiaojian Zhu, et al.. (2016). miR-146b-5p within BCR-ABL1–Positive Microvesicles Promotes Leukemic Transformation of Hematopoietic Cells. Cancer Research. 76(10). 2901–2911. 81 indexed citations
20.
Zhu, Xiaojian, Y. Nancy You, Chen Zeng, et al.. (2014). BCR-ABL1–positive microvesicles transform normal hematopoietic transplants through genomic instability: implications for donor cell leukemia. Leukemia. 28(8). 1666–1675. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Catalin Mihalcioiu Breakdown of academic impact, for papers by Francis Mussai Breakdown of academic impact, for papers by Denise Toscani Breakdown of academic impact, for papers by Frédéric Barabé Breakdown of academic impact, for papers by Hyung‐Gyoon Kim Breakdown of academic impact, for papers by Dina Stroopinsky Breakdown of academic impact, for papers by Tae Kon Kim Breakdown of academic impact, for papers by Andrea Pelosi Breakdown of academic impact, for papers by Laurence Maggiorella Breakdown of academic impact, for papers by Bonnie K. Arendt
Rankless by CCL
2026